General MedicationsINJECTIONGeneric
MEZLIN
MEZLOCILLIN SODIUM MONOHYDRATE
Standard Dose
EQ 20GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview MEZLIN is listed in Drugs@FDA under application 062372 (ANDA).
Marketing status: Discontinued Active ingredient MEZLOCILLIN SODIUM MONOHYDRATE Form and strength INJECTABLE;INJECTION - EQ 20GM BASE/VIAL Sponsor BAYER PHARMS Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview MEZLIN is listed in Drugs@FDA under application 062372 (ANDA). Marketing status: Discontinued Active ingredient MEZLOCILLIN SODIUM MONOHYDRATE Form and strength INJECTABLE;INJECTION - EQ 20GM BASE/VIAL Sponsor BAYER PHARMS Submission history See approval history documents.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.